This article examines how bioprinting improves cancer models, overcoming traditional limits and advancing current therapies.

A token leaks. A bad package slips in. A login trick works. An old tool shows up again. At first, it feels like the usual mess. Then you see the pattern: attackers are not always breaking in. They are ...

From this summer, five courses at Goldsmiths, University of London will be delivered 100% online. Here’s how these qualifications will break new ground, offering students unrivalled flexibility, a ...

AI agents can use tools, plan workflows, and complete tasks beyond chatbot replies, but businesses need clear guardrails ...

Facilities are scaling rapidly, densities are increasing with force, and expectations around performance, uptime, and energy ...

Sky bridge systems connect tall buildings, enhancing safety and structural performance while offering unique amenities like ...

Electrical synapses containing Connexin 36 (Cx36) represent the main means for direct electrical communication among neurons in the mammalian nervous system. However, little is kn ...

Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION, a tumor-activated oncology delivery platform today published its unaudited ...

How synthetic identities, deepfakes, and generative AI are forcing banks to rethink fraud prevention, identity assurance, and ...

We believe Brenntag trades at an attractive valuation and are encouraged by the new management team’s recent efforts to ...